biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	CF3D66D7-BD85-49B6-88DC-6AE31919874D
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-2Y-A9H6-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-2Y-A9H6-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-2Y-A9H6-01A
biospecimen__bio__biospecimen_barcode_bottom	0167788104
biospecimen__bio__day_of_creation	13
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-2Y-A9H6.0B39CB6A-D208-4128-AB46-50C7DB072865.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A39J
biospecimen__bio__plate_row	B
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-2Y-A9H6
biospecimen__shared__patient_id	A9H6
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	FE1E11EE-CD01-4E52-BDBB-4944E2CA42B8
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.3
clinical__chol_lihc_shared__bilirubin_upper_limit	0.3
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	7
clinical__chol_lihc_shared__fetoprotein_outcome_value	114
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	11.5
clinical__chol_lihc_shared__platelet_result_lower_limit	143
clinical__chol_lihc_shared__platelet_result_upper_limit	382
clinical__chol_lihc_shared__prothrombin_time_result_value	10.5
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	68
clinical__clin_shared__bcr_followup_barcode	TCGA-2Y-A9H6-F69088
clinical__clin_shared__bcr_followup_uuid	3761694C-88B1-42BD-B2B5-3FF86FC9641D
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__platelet_result_count	224
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	Yes
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	39818807-039f-4b47-99f9-0f5763c99fcf
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-2Y-A9H6-01A-11R-A39J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	ded27bba-9853-4239-a8f7-9a4b39488d73
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.82
gdc__analytes__analyte_id	ba1f5b5a-a8a8-4127-ac81-d053eb6cf008
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	bc3502bc-bbf6-44f2-a1f4-d1567819aefb
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:29:32.212662-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	6f1177a7-46f1-5fc0-8f6d-ef370f7a7339
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1943
gdc__diagnoses__age_at_diagnosis	24982
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24982.0
gdc__diagnoses__days_to_last_follow_up	357.0
gdc__diagnoses__diagnosis_id	f47783d4-790e-5d80-9eb2-d719d6b8ba6f
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	40.68047337278106
gdc__exposures__exposure_id	aa405aeb-96df-5485-bad8-8879d705ab34
gdc__exposures__height	156.0
gdc__exposures__weight	99.0
gdc__file_id	e931fb80-682c-4f7f-9bd8-c7dd16997552
gdc__file_name	ac615e2d-87bb-4d61-b1e7-64db75196c16.mirbase21.mirnas.quantification.txt
gdc__file_size	50411
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	2bdc5d6771e118ed42e02e3ec5a097f4
gdc__portions__is_ffpe	false
gdc__portions__portion_id	3615c427-5c01-4998-8779-a166b9f3528c
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	982
gdc__samples__initial_weight	100.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	0B39CB6A-D208-4128-AB46-50C7DB072865
gdc__samples__sample_id	9bf4058e-e487-4033-88d9-4951f47afe4c
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	2.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	db35d8e4-81c0-485e-b9f2-b2383b613fe1
gdc__submitter_id	mirna_swap_dr11_20_MirnaExpressiondea3212d-fac8-4cce-add1-d28b18c84984_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	2Y
gdc__tissue_source_site__name	Moffitt Cancer Center
gdc__tissue_source_site__tissue_source_site_id	33e340f9-a97a-56eb-a3e6-aad831681cb4
gdc__treatments__treatment_id	deb8ee2d-67ac-50e9-9f0c-199030face37
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:52.857+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/39818807-039f-4b47-99f9-0f5763c99fcf-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/39818807-039f-4b47-99f9-0f5763c99fcf-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129782
manually_curated__local_md5	e4072fd8d0865e31b4a150ae442e6db4
manually_curated__opengdc_download_date	2018-10-16T17:11:04.000812+02:00
manually_curated__opengdc_file_md5	a5f7090524fb9a38a5e448d691c5daa7
manually_curated__opengdc_file_size	50410
manually_curated__opengdc_id	39818807-039f-4b47-99f9-0f5763c99fcf-meq
manually_curated__origin_file_size	129782
manually_curated__origin_last_modified_date	Tue Oct 16 17:15:00 CEST 2018
manually_curated__origin_md5	e4072fd8d0865e31b4a150ae442e6db4
manually_curated__tissue_status	tumoral
